Global Cryotherapy Market
Description
MARKET SCOPE:
The global Cryotherapy market is projected to grow significantly, registering a CAGR of 9.1% during the forecast period (2024 – 2032).
Cryotherapy is a pain management procedure that employs localized freezing temperatures to eliminate an irritated nerve, abnormal skin cells, or specific areas of certain cancers (referred to as cryosurgery), such as prostate cancer and skin cancer. During cryotherapy, a probe is inserted into the tissue adjacent to the affected nerve to induce freezing. This freezing process deactivates the nerve, leading to the alleviation of painful nerve irritation. Cryotherapy is considered a relatively safe and effective approach for treating localized nerve irritation. Cryotherapy involves the application of extremely low temperatures in medical treatment or surgery. It is primarily utilized for the treatment of cancer and dermatologic diseases. The increasing prevalence of patients suffering from cancer and dermatologic conditions is anticipated to drive a surge in product launches within the global cryotherapy market.
MARKET OVERVIEW:
Driver: The rise in patients of dermatologic disorders and cancer as well as high preference of physicians for cryotherapy worldwide is driving the market growth.
The growing prevalence of dermatologic disorders and cancer is driving the demand for cryotherapy, contributing to the anticipated growth of the global cryotherapy market during the forecast period. For example, a report published on April 17, 2023, by the National Center for Biotechnology Information (NCBI) identified a global total of 4,859,267,654 new cases of skin and subcutaneous diseases in 2019, with a majority comprising fungal and bacterial skin conditions. The increasing preference among physicians for cryotherapy is expected to boost the demand for this treatment, thereby fostering the growth of the global cryotherapy market. In a related development, on April 24, 2023, IceCure Medical Ltd., the developer of the ProSense System, a minimally-invasive cryoablation technology designed to destroy tumors by freezing as an alternative to surgical tumor removal, announced its educational support for a Continuing Medical Education (CME) course on cryotherapy. This course was conducted at the 24th Annual Meeting of the American Society of Breast Surgeons (ASBrS) held in Boston, U.S.
Opportunities: Technological advancements in cryotherapy equipment are expected to pave the way for cryotherapy market growth in the upcoming years.
Cryotherapy has emerged as a crucial treatment option, primarily driven by continuous technological innovations and advancements in cryotherapy equipment. Notable progress has been witnessed across various types of equipment, including cryosurgery units and accessories. Developments in cryochambers and cryosaunas, extensively utilized for treating inflammation, rheumatoid arthritis, pain management, as well as general beauty and wellness therapies, have contributed to their enhancement. Additionally, significant advancements have been made in cryosurgical equipment, incorporating the utilization of supercooled liquid nitrogen or other cryogens for cooling, the introduction of thin and efficient probes in various sizes, and the adoption of narrow and improved cryoablation needles. For example, in September 2018, Galil Medical introduced the ICEfx cryoablation system as an upgrade to the existing Visual ICE system. This new system features an advanced needle platform with helium-free thaw capability, aimed at accelerating thaw-time while eliminating the cost associated with helium. The ICEfx cryoablation system is compact, easily mobilized, and simplifies procedures through user-friendly on-screen prompts.
COVID IMPACT:
Since the outbreak of the COVID-19 virus in December 2019, the disease has rapidly spread to over 100 countries worldwide, prompting the World Health Organization (WHO) to declare it a public health emergency on January 30, 2020. The impact of COVID-19 on the global economy has been threefold: it directly influenced the production and demand for drugs, created disruptions in distribution channels, and had financial ramifications for firms and financial markets. The implementation of nationwide lockdowns in various countries, including China, India, Saudi Arabia, the U.A.E., Egypt, and others, has resulted in challenges related to the transportation of goods. However, the COVID-19 pandemic has had a detrimental effect on the global cryotherapy market. This is attributed to a decrease in bed and operating room capacity, leading to significant delays in urgent and semi-elective surgical interventions. As per a 2021 report by the American College of Surgeons (ACSs), there was a shift in the nature of surgery and anesthesia practices during the COVID-19 pandemic, with the postponement of most elective and non-urgent cases.
SEGMENTATION ANALYSIS:
The oncology segment is anticipated to grow significantly during the forecast period.
Cryotherapy finds application in the treatment of various cancers, as well as certain precancerous or noncancerous conditions. Alongside prostate and liver tumors, cryosurgery proves effective for treating Retinoblastoma, early-stage skin cancers (both basal cell and squamous cell carcinomas), actinic keratosis (precancerous skin growths), and cervical intraepithelial neoplasia (precancerous conditions of the cervix). The oncology segment is anticipated to dominate the market share during the forecast period due to the high incidence and prevalence of cancer, coupled with the growing awareness of different cryotherapy approaches.
Minimally invasive ablative procedures have gained popularity as alternatives for cancer treatment and surgical tumor removal, driven by advancements in modern imaging. Tumor ablation modalities, including cryoablation procedures, are extensively utilized in clinical practice. Ongoing research into the impact of cryotherapy on cancer treatment is also on the rise. For example, a February 2022 research article titled 'Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation' highlighted advancements in cryoablation cancer therapy and the potential role of multifunctional nanocarriers in expanding cryoablation for cancer treatment.
The extensive and increasing research on the benefits of cryotherapy and combination cryoablation cancer therapies is expected to create better opportunities for the oncology segment. Insights into heightened R&D activities within the segment are predicted to drive its growth. For instance, in April 2021, IceCure Medical Ltd., a developer of next-generation cryoablation technology, received Breakthrough Device Designation from the FDA for its lead asset, ProSense. This liquid-nitrogen-based cryoablation system enables minimally-invasive treatment of cancer tumors. As a result, the oncology segment is experiencing significant growth and is expected to continue this trend over the forecast period, thereby contributing to the overall expansion of the studied market.
The hospital and specialty clinic segment is anticipated to grow significantly during the forecast period.
The end-user segment, specifically hospitals and specialty clinics, is poised to demonstrate the highest growth rate during the entire forecast period, reaching 8.1%. This heightened growth is driven by the growing demand for cryosurgery and associated products in hospitals and specialized clinics, fueled by advancements in cryotherapy technology for treating diverse diseases and disorders. The adoption of cryotherapy-based treatments is becoming increasingly prevalent in numerous hospitals and clinics. Over the forecast period, the segment dedicated to cryotherapy centers is expected to experience substantial growth. This growth is likely attributed to the expansion of cryotherapy facilities in key markets. Notably, in October 2021, CARE Innovative Options unveiled the Slynarski Knee Clinic, introducing computer-controlled cryotherapy solutions tailored for knee-related treatments. This development is indicative of the expanding landscape of cryotherapy centers, contributing to the overall lucrative growth anticipated in this segment throughout the projection period.
REGIONAL ANALYSIS:
The North American region is set to witness significant growth during the forecast period.
North America stands as the largest regional market in revenue terms, propelled by substantial healthcare expenditure from local governments and the highly developed healthcare infrastructure in the United States (US) and Canada. Additionally, the availability of well-established cryotherapy products in this region is expected to contribute to market growth throughout the forecast period. The dominant factors influencing overall market growth in North America include robust healthcare expenditure, the presence of skilled professionals, a growing adoption of whole-body cryotherapy, an increasing inclination toward cryotherapy for cancers and skin disorders, a rising prevalence of cancer, and an upsurge in the adoption of minimally invasive surgeries. A key driver for this growth is the prevalence of cancer, as indicated by the Cancer Facts & Figures 2022 published by the American Cancer Society. The report estimates approximately 1.9 million new cancer cases to be diagnosed in the US. Notably, cancer ranks as the second most common cause of death in the US, following heart disease. The anticipated growth of the cryotherapy market in the region is further fueled by the recognized benefits of cryotherapy in cancer treatment and its application in the surgical removal of tumors. As a result, North America is poised for significant expansion in the cryotherapy market, driven by the convergence of these favorable factors.
COMPETITIVE ANALYSIS
The global Cryotherapy market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.
Medtronic
In 2019, Medtronic entered into a collaboration with Philips, a Netherlands-based company, to enable the sales of products on behalf of Philips. This collaboration aims to offer an innovative and integrated image guidance solution designed for cryoablation procedures, specifically for the advanced treatment of paroxysmal atrial fibrillation (PAF), a prevalent heart rhythm disorder.
Galil Medical
CooperSurgical
Cryotherapy
Zimmer MedizinSysteme
Metrum Cryoflex
Brymill Cryogenic Systems
Erbe Elektromedizin
CryoConcepts
US Cryotherapy
Professional Products
KriosystemLife
SCOPE OF THE REPORT
By Product
Cryosurgery Devices
Localized Cryotherapy Devices
Cryosaunas
By Application
Surgical Application
Oncology
Cardiology
Dermatology
Pain Management
Health & Beauty
By End User
Hospitals & Specialty Clinics
Spas
By Region
North America (the United States & Canada)
Europe (Germany, UK, France, Spain, Italy, and the Rest of Europe)
Asia Pacific (China, Japan, India, and Rest of Asia Pacific)
Rest of the World (the Middle East & Africa, and Latin America)
KEY REASONS TO PURCHASE THIS REPORT
It provides a technological development map over time to understand the industry’s growth rate and indicates how the Cryotherapy market is evolving.
The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which Cryotherapy submarket will be the main driver of the overall market from 2024 to 2032.
It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.
It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2032 and which country will lead the market in 2032.
The global Cryotherapy market is projected to grow significantly, registering a CAGR of 9.1% during the forecast period (2024 – 2032).
Cryotherapy is a pain management procedure that employs localized freezing temperatures to eliminate an irritated nerve, abnormal skin cells, or specific areas of certain cancers (referred to as cryosurgery), such as prostate cancer and skin cancer. During cryotherapy, a probe is inserted into the tissue adjacent to the affected nerve to induce freezing. This freezing process deactivates the nerve, leading to the alleviation of painful nerve irritation. Cryotherapy is considered a relatively safe and effective approach for treating localized nerve irritation. Cryotherapy involves the application of extremely low temperatures in medical treatment or surgery. It is primarily utilized for the treatment of cancer and dermatologic diseases. The increasing prevalence of patients suffering from cancer and dermatologic conditions is anticipated to drive a surge in product launches within the global cryotherapy market.
MARKET OVERVIEW:
Driver: The rise in patients of dermatologic disorders and cancer as well as high preference of physicians for cryotherapy worldwide is driving the market growth.
The growing prevalence of dermatologic disorders and cancer is driving the demand for cryotherapy, contributing to the anticipated growth of the global cryotherapy market during the forecast period. For example, a report published on April 17, 2023, by the National Center for Biotechnology Information (NCBI) identified a global total of 4,859,267,654 new cases of skin and subcutaneous diseases in 2019, with a majority comprising fungal and bacterial skin conditions. The increasing preference among physicians for cryotherapy is expected to boost the demand for this treatment, thereby fostering the growth of the global cryotherapy market. In a related development, on April 24, 2023, IceCure Medical Ltd., the developer of the ProSense System, a minimally-invasive cryoablation technology designed to destroy tumors by freezing as an alternative to surgical tumor removal, announced its educational support for a Continuing Medical Education (CME) course on cryotherapy. This course was conducted at the 24th Annual Meeting of the American Society of Breast Surgeons (ASBrS) held in Boston, U.S.
Opportunities: Technological advancements in cryotherapy equipment are expected to pave the way for cryotherapy market growth in the upcoming years.
Cryotherapy has emerged as a crucial treatment option, primarily driven by continuous technological innovations and advancements in cryotherapy equipment. Notable progress has been witnessed across various types of equipment, including cryosurgery units and accessories. Developments in cryochambers and cryosaunas, extensively utilized for treating inflammation, rheumatoid arthritis, pain management, as well as general beauty and wellness therapies, have contributed to their enhancement. Additionally, significant advancements have been made in cryosurgical equipment, incorporating the utilization of supercooled liquid nitrogen or other cryogens for cooling, the introduction of thin and efficient probes in various sizes, and the adoption of narrow and improved cryoablation needles. For example, in September 2018, Galil Medical introduced the ICEfx cryoablation system as an upgrade to the existing Visual ICE system. This new system features an advanced needle platform with helium-free thaw capability, aimed at accelerating thaw-time while eliminating the cost associated with helium. The ICEfx cryoablation system is compact, easily mobilized, and simplifies procedures through user-friendly on-screen prompts.
COVID IMPACT:
Since the outbreak of the COVID-19 virus in December 2019, the disease has rapidly spread to over 100 countries worldwide, prompting the World Health Organization (WHO) to declare it a public health emergency on January 30, 2020. The impact of COVID-19 on the global economy has been threefold: it directly influenced the production and demand for drugs, created disruptions in distribution channels, and had financial ramifications for firms and financial markets. The implementation of nationwide lockdowns in various countries, including China, India, Saudi Arabia, the U.A.E., Egypt, and others, has resulted in challenges related to the transportation of goods. However, the COVID-19 pandemic has had a detrimental effect on the global cryotherapy market. This is attributed to a decrease in bed and operating room capacity, leading to significant delays in urgent and semi-elective surgical interventions. As per a 2021 report by the American College of Surgeons (ACSs), there was a shift in the nature of surgery and anesthesia practices during the COVID-19 pandemic, with the postponement of most elective and non-urgent cases.
SEGMENTATION ANALYSIS:
The oncology segment is anticipated to grow significantly during the forecast period.
Cryotherapy finds application in the treatment of various cancers, as well as certain precancerous or noncancerous conditions. Alongside prostate and liver tumors, cryosurgery proves effective for treating Retinoblastoma, early-stage skin cancers (both basal cell and squamous cell carcinomas), actinic keratosis (precancerous skin growths), and cervical intraepithelial neoplasia (precancerous conditions of the cervix). The oncology segment is anticipated to dominate the market share during the forecast period due to the high incidence and prevalence of cancer, coupled with the growing awareness of different cryotherapy approaches.
Minimally invasive ablative procedures have gained popularity as alternatives for cancer treatment and surgical tumor removal, driven by advancements in modern imaging. Tumor ablation modalities, including cryoablation procedures, are extensively utilized in clinical practice. Ongoing research into the impact of cryotherapy on cancer treatment is also on the rise. For example, a February 2022 research article titled 'Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation' highlighted advancements in cryoablation cancer therapy and the potential role of multifunctional nanocarriers in expanding cryoablation for cancer treatment.
The extensive and increasing research on the benefits of cryotherapy and combination cryoablation cancer therapies is expected to create better opportunities for the oncology segment. Insights into heightened R&D activities within the segment are predicted to drive its growth. For instance, in April 2021, IceCure Medical Ltd., a developer of next-generation cryoablation technology, received Breakthrough Device Designation from the FDA for its lead asset, ProSense. This liquid-nitrogen-based cryoablation system enables minimally-invasive treatment of cancer tumors. As a result, the oncology segment is experiencing significant growth and is expected to continue this trend over the forecast period, thereby contributing to the overall expansion of the studied market.
The hospital and specialty clinic segment is anticipated to grow significantly during the forecast period.
The end-user segment, specifically hospitals and specialty clinics, is poised to demonstrate the highest growth rate during the entire forecast period, reaching 8.1%. This heightened growth is driven by the growing demand for cryosurgery and associated products in hospitals and specialized clinics, fueled by advancements in cryotherapy technology for treating diverse diseases and disorders. The adoption of cryotherapy-based treatments is becoming increasingly prevalent in numerous hospitals and clinics. Over the forecast period, the segment dedicated to cryotherapy centers is expected to experience substantial growth. This growth is likely attributed to the expansion of cryotherapy facilities in key markets. Notably, in October 2021, CARE Innovative Options unveiled the Slynarski Knee Clinic, introducing computer-controlled cryotherapy solutions tailored for knee-related treatments. This development is indicative of the expanding landscape of cryotherapy centers, contributing to the overall lucrative growth anticipated in this segment throughout the projection period.
REGIONAL ANALYSIS:
The North American region is set to witness significant growth during the forecast period.
North America stands as the largest regional market in revenue terms, propelled by substantial healthcare expenditure from local governments and the highly developed healthcare infrastructure in the United States (US) and Canada. Additionally, the availability of well-established cryotherapy products in this region is expected to contribute to market growth throughout the forecast period. The dominant factors influencing overall market growth in North America include robust healthcare expenditure, the presence of skilled professionals, a growing adoption of whole-body cryotherapy, an increasing inclination toward cryotherapy for cancers and skin disorders, a rising prevalence of cancer, and an upsurge in the adoption of minimally invasive surgeries. A key driver for this growth is the prevalence of cancer, as indicated by the Cancer Facts & Figures 2022 published by the American Cancer Society. The report estimates approximately 1.9 million new cancer cases to be diagnosed in the US. Notably, cancer ranks as the second most common cause of death in the US, following heart disease. The anticipated growth of the cryotherapy market in the region is further fueled by the recognized benefits of cryotherapy in cancer treatment and its application in the surgical removal of tumors. As a result, North America is poised for significant expansion in the cryotherapy market, driven by the convergence of these favorable factors.
COMPETITIVE ANALYSIS
The global Cryotherapy market is reasonably competitive with mergers, acquisitions, and product launches. See some of the major key players in the market.
Medtronic
In 2019, Medtronic entered into a collaboration with Philips, a Netherlands-based company, to enable the sales of products on behalf of Philips. This collaboration aims to offer an innovative and integrated image guidance solution designed for cryoablation procedures, specifically for the advanced treatment of paroxysmal atrial fibrillation (PAF), a prevalent heart rhythm disorder.
Galil Medical
CooperSurgical
Cryotherapy
Zimmer MedizinSysteme
Metrum Cryoflex
Brymill Cryogenic Systems
Erbe Elektromedizin
CryoConcepts
US Cryotherapy
Professional Products
KriosystemLife
SCOPE OF THE REPORT
By Product
Cryosurgery Devices
Localized Cryotherapy Devices
Cryosaunas
By Application
Surgical Application
Oncology
Cardiology
Dermatology
Pain Management
Health & Beauty
By End User
Hospitals & Specialty Clinics
Spas
By Region
North America (the United States & Canada)
Europe (Germany, UK, France, Spain, Italy, and the Rest of Europe)
Asia Pacific (China, Japan, India, and Rest of Asia Pacific)
Rest of the World (the Middle East & Africa, and Latin America)
KEY REASONS TO PURCHASE THIS REPORT
It provides a technological development map over time to understand the industry’s growth rate and indicates how the Cryotherapy market is evolving.
The report offers a dynamic method to various factors that drive or restrain the growth of the market and specifies which Cryotherapy submarket will be the main driver of the overall market from 2024 to 2032.
It renders a definite analysis of changing competitive dynamics and stipulates the leading players and what are their prospects over the forecast period.
It builds a nine-year estimate based on how the market is predicted to grow and shows what will market shares of the global region change by 2032 and which country will lead the market in 2032.
Table of Contents
167 Pages
- 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Regional Analysis
- 1.3. Segment Analysis
- 2. Overview And Scope
- 2.1. Market Vision
- 2.1.1. Market Definition
- 2.2. Market Segmentation
- 3. Global Cryotherapy Market Overview By Region: 2019 Vs 2023 Vs 2032
- 3.1. Global Cryotherapy Market Size By Regions (2019-2023) (Usd Million)
- 3.1.1. North America Cryotherapy Market Size By Country (2019-2023) (Usd Million)
- 3.1.2. Europe Cryotherapy Market Size By Country (2019-2023) (Usd Million)
- 3.1.3. Asia Pacific America Cryotherapy Market Size By Country (2019-2023) (Usd Million)
- 3.1.4. Rest Of The World Cryotherapy Market Size By Country (2019-2023) (Usd Million)
- 3.2. Global Cryotherapy Market Size By Regions (2024-2032) (Usd Million)
- 3.2.1. North America Cryotherapy Market Size By Country (2024-2032) (Usd Million)
- 3.2.2. Europe Cryotherapy Market Size By Country (2024-2032) (Usd Million)
- 3.2.3. Asia Pacific Cryotherapy Market Size By Country (2024-2032) (Usd Million)
- 3.2.4. Rest Of The World Cryotherapy Market Size By Country (2024-2032) (Usd Million)
- 4. Global Cryotherapy Market Dynamics
- 4.1. Market Overview
- 4.1.1. Market Drivers
- 4.1.2. Market Restraints/ Challenges Analysis
- 4.1.3. Market Opportunities
- 4.2. Pestle Analysis
- 4.3. Porter’s Five Forces Model
- 4.3.1. Bargaining Power Of Suppliers
- 4.3.2. Bargaining Power Of Buyers
- 4.3.3. The Threat Of New Entrants
- 4.3.4. Threat Of Substitutes
- 4.3.5. Intensity Of Rivalry
- 4.4. Value Chain Analysis/Supply Chain Analysis
- 4.5. Covid-19 Impact Analysis On Global Cryotherapy Market
- ** In – Depth Qualitative Analysis Will Be Provided In The Final Report Subject To Market
- 5. Global Cryotherapy Market, By Product
- 5.1. Overview
- 5.2. Global Cryotherapy Market Size By Product
- 5.3. Key Findings For Cryotherapy Market - By Product
- 5.3.1. Cryosurgery Devices
- 5.3.2. Localized Cryotherapy Devices
- 5.3.3. Cryosaunas
- 6. Global Cryotherapy Market, By Application
- 6.1. Overview
- 6.2. Key Findings For Cryotherapy Market - By Application
- 6.2.1. Surgical Application
- 6.2.1.1. Oncology
- 6.2.1.2. Cardiology
- 6.2.1.3. Dermatology
- 6.2.2. Pain Management
- 6.2.3. Health & Beauty
- 7. Global Cryotherapy Market, By End User
- 7.1. Overview
- 7.2. Key Findings For Cryotherapy Market - By End User
- 7.2.1. Hospitals & Specialty Clinics
- 7.2.2. Spas
- 8. Global Cryotherapy Market, By Region
- 8.1. Key Findings For Cryotherapy Market- By Region
- 8.2. Overview
- 8.3. Global Cryotherapy Market, By Product
- 8.4. Global Cryotherapy Market, By Application
- 8.5. Global Cryotherapy Market, By End User
- 9. Global Cryotherapy Market- North America
- 9.1. Overview
- 9.2. North America Cryotherapy Market Size (2019 - 2032) (Usd Million)
- 9.3. North America Cryotherapy Market, By Product
- 9.4. North America Cryotherapy Market, By Application
- 9.5. North America Cryotherapy Market, By End User
- 9.6. North America Cryotherapy Market Size By Countries
- 9.6.1. United States
- 9.6.2. Canada
- 10. Global Cryotherapy Market- Europe
- 10.1. Overview
- 10.2. Europe Cryotherapy Market Size (2019 - 2032) (Usd Million)
- 10.3. Europe Cryotherapy Market, By Product
- 10.4. Europe Cryotherapy Market, By Application
- 10.5. Europe Cryotherapy Market, By End User
- 10.6. Europe Cryotherapy Market Size By Countries
- 10.6.1. Germany
- 10.6.2. Uk
- 10.6.3. France
- 10.6.4. Spain
- 10.6.5. Italy
- 10.6.6. Rest Of Europe
- 11. Global Cryotherapy Market - Asia Pacific
- 11.1. Overview
- 11.2. Asia Pacific Cryotherapy Market Size (2019 - 2032) (Usd Million)
- 11.3. Asia Pacific Cryotherapy Market, By Product
- 11.4. Asia Pacific Cryotherapy Market, By Application
- 11.5. Asia Pacific Cryotherapy Market, By End User
- 11.6. Asia Pacific Cryotherapy Market Size By Countries
- 11.6.1. China
- 11.6.2. Japan
- 11.6.3. India
- 11.6.4. Rest Of Asia Pacific
- 12. Global Cryotherapy Market- Rest Of World
- 12.1. Overview
- 12.2. Rest Of World Cryotherapy Market Size (2019 - 2032) (Usd Million)
- 12.3. Rest Of World Cryotherapy Market, By Product
- 12.4. Rest Of World Cryotherapy Market, By Application
- 12.5. Rest Of World Cryotherapy Market, By End User
- 12.6. Rest Of World Cryotherapy Market Size By Regions
- 12.6.1. Middle East & Africa
- 12.6.2. Latin America
- 13. Global Cryotherapy Market- Competitive Landscape
- 13.1. Key Strategies Adopted By The Leading Players
- 13.2. Recent Developments
- 13.2.1. Investments & Expansions
- 13.2.2. New End-user Launches
- 13.2.3. Mergers & Acquisitions
- 13.2.4. Agreements, Joint Ventures, And Partnerships
- 14. Global Cryotherapy Market- Company Profiles
- 14.1. Medtronic
- 14.1.1. Company Overview
- 14.1.2. Financial Overview
- 14.1.3. Product Offered
- 14.1.4. Key Developments
- 14.2. Galil Medical
- 14.3. Coopersurgical
- 14.4. Cryotherapy
- 14.5. Zimmer Medizinsysteme
- 14.6. Metrum Cryoflex
- 14.7. Brymill Cryogenic Systems
- 14.8. Erbe Elektromedizin
- 14.9. Cryoconcepts
- 14.10. Us Cryotherapy
- 14.11. Professional Products
- 14.12. Kriosystem Life
- 15. Our Research Methodology
- 15.1. Data Triangulation
- 15.2. Data Sources
- 15.2.1. Secondary Sources
- 15.2.2. Primary Sources
- 15.3. Assumptions/ Limitations For The Study
- 15.4. Research & Forecasting Methodology
- 16. Appendix
- 16.1. Disclaimer
- 16.2. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
